(1) Ji, Guanjie.Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma.Heliyon.2024,10 (2)
(2) Hao, Yanyun.Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis.Journal of Controlled Release.2023,361 :64-76
(3) Hao, Yanyun.Ferrocene-conjugated polymeric platform via amide bond formation facilitates enhanced in situ fenton reaction and robust immune responses in combination with toll-like receptor 7/8 agonist.Chemical Engineering Journal.2023,472
(4) Lingling Huang .The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy.PHARMACEUTICS.2022 (6)
(5) In Situ Tumor Vaccination with Calcium-Linked Degradable Coacervate Nanocomplex Co-Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti-Tumor Immune Responses.Advanced Healthcare Materials.2022 (11)
(6) 李慧.Imidazoquinoline-Conjugated Degradable Coacervate Conjugate for Local Cancer Immunotherapy.ACS BIOMATERIALS-SCIENCE & ENGINEERING.2020 (6)
(7) Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy.Journal of Nanobiotechnology.2022 (1)
1. （包干项目）基于纳米杂合中性粒细胞的整合应激稳态“破坏加速器”逆转结直肠癌治疗耐受研究, 2024/08/23-2027/12/31
